Prognostic benefit of POLE exonuclease domain mutations in endometrial cancer cannot be explained by increased sensitivity to adjuvant treatment strategies

Prognostic benefit of POLE exonuclease domain mutations in endometrial cancer cannot be explained by increased sensitivity to adjuvant treatment strategies

Chi tiết về thư mục
Những tác giả chính: Van Gool, I, Rayner, E, Osse, E, Tomlinson, I, Smit, V, Creutzberg, C, Church, D, de Wind, N, Bosse, T, Drost, M
Định dạng: Conference item
Được phát hành: Wolters Kluwer 2017

Những quyển sách tương tự